Index by author
June 01, 2005; Volume 33,Issue 6
A
Abe, Daisuke
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
Anzenbacher, Pavel
- You have accessMINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYMEJana Baranová, Eva Anzenbacherová, Pavel Anzenbacher and Pavel SoučekDrug Metabolism and Disposition June 2005, 33 (6) 862-865; DOI: https://doi.org/10.1124/dmd.104.003392
Anzenbacherová, Eva
- You have accessMINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYMEJana Baranová, Eva Anzenbacherová, Pavel Anzenbacher and Pavel SoučekDrug Metabolism and Disposition June 2005, 33 (6) 862-865; DOI: https://doi.org/10.1124/dmd.104.003392
Arthaud, Larry
- You have accessTHE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATSPeter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. RoseDrug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
Attaccalite, Silvia
- You have accessDETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAYAnnalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph LauferDrug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333
B
Baranová, Jana
- You have accessMINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYMEJana Baranová, Eva Anzenbacherová, Pavel Anzenbacher and Pavel SoučekDrug Metabolism and Disposition June 2005, 33 (6) 862-865; DOI: https://doi.org/10.1124/dmd.104.003392
Baronas, Elizabeth
- You have accessHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITESTeresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald MiwaDrug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
Baughman, T. M.
- You have accessMETABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTEST. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. ZhaoDrug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
Bonate, Peter L.
- You have accessTHE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATSPeter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. RoseDrug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
Bumpus, Namandjé N.
- You have accessTHE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATIONNamandjé N. Bumpus, Chitra Sridar, Ute M. Kent and Paul F. HollenbergDrug Metabolism and Disposition June 2005, 33 (6) 795-802; DOI: https://doi.org/10.1124/dmd.105.003749
Burczynski, Frank J.
- You have accessMETABOLISM OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE AND ONE OF ITS METABOLITES BY ISOLATED RAT MYOCYTES, HEPATOCYTES, AND BLOODPatricia E. Schroeder, Gu-Qi Wang, Frank J. Burczynski and Brian B. HasinoffDrug Metabolism and Disposition June 2005, 33 (6) 719-725; DOI: https://doi.org/10.1124/dmd.104.003186
C
Caldwell, Gary W.
- You have accessDETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDESZhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua ZhongDrug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
Carotenuto, Pietro
- You have accessDETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAYAnnalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph LauferDrug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333
Chen, Xiaoyan
- You have accessROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANSYingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui ZhouDrug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
Choi, Man Ho
- You have accessCHARACTERIZATION OF TESTOSTERONE 11β-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450Man Ho Choi, Paul L. Skipper, John S. Wishnok and Steven R. TannenbaumDrug Metabolism and Disposition June 2005, 33 (6) 714-718; DOI: https://doi.org/10.1124/dmd.104.003327
D
D'Antoni, Michelle
- You have accessDETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAYAnnalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph LauferDrug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333
Daniels, J. Scott
- You have accessHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITESTeresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald MiwaDrug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
Di Marco, Annalise
- You have accessDETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAYAnnalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph LauferDrug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333
Du, Yanming
- You have accessDETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDESZhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua ZhongDrug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
Duan, Su X.
- You have accessATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITROElke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von MoltkeDrug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931
F
Fawcett, J. Paul
- You have accessROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANSYingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui ZhouDrug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
Fujishima, Toshie
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
G
Gan, Liang-Shang
- You have accessHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITESTeresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald MiwaDrug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
Graham, R. A.
- You have accessMETABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTEST. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. ZhaoDrug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
Greenblatt, David J.
- You have accessATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITROElke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von MoltkeDrug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931
Gunnarsson, Per Olov
- You have accessCYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATORHelén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric SeidegårdDrug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
Guo, Yingjie
- You have accessROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANSYingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui ZhouDrug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
Gupta, Anshul
- You have accessFUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620NR. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
H
Hallifax, David
- You have accessIMPACT OF PARALLEL PATHWAYS OF DRUG ELIMINATION AND MULTIPLE CYTOCHROME P450 INVOLVEMENT ON DRUG-DRUG INTERACTIONS: CYP2D6 PARADIGMKiyomi Ito, David Hallifax, R. Scott Obach and J. Brian HoustonDrug Metabolism and Disposition June 2005, 33 (6) 837-844; DOI: https://doi.org/10.1124/dmd.105.003715
Hallin, Ingrid
- You have accessCYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATORHelén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric SeidegårdDrug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
Hamamoto, Hiromi
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
Hartmann, Georgy
- You have accessIMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICEGeorgy Hartmann, Vessela Vassileva and Micheline Piquette-MillerDrug Metabolism and Disposition June 2005, 33 (6) 820-828; DOI: https://doi.org/10.1124/dmd.104.002568
Hasinoff, Brian B.
- You have accessMETABOLISM OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE AND ONE OF ITS METABOLITES BY ISOLATED RAT MYOCYTES, HEPATOCYTES, AND BLOODPatricia E. Schroeder, Gu-Qi Wang, Frank J. Burczynski and Brian B. HasinoffDrug Metabolism and Disposition June 2005, 33 (6) 719-725; DOI: https://doi.org/10.1124/dmd.104.003186
Hollenberg, Paul F.
- You have accessTHE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATIONNamandjé N. Bumpus, Chitra Sridar, Ute M. Kent and Paul F. HollenbergDrug Metabolism and Disposition June 2005, 33 (6) 795-802; DOI: https://doi.org/10.1124/dmd.105.003749
Horie, Toru
- You have accessIN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVERMiki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi YokoiDrug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
Horie, Toshiharu
- You have accessACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMESMasaya Tachibana, Makoto Tanaka, Yasuhiro Masubuchi and Toshiharu HorieDrug Metabolism and Disposition June 2005, 33 (6) 803-811; DOI: https://doi.org/10.1124/dmd.104.003178
Houston, J. Brian
- You have accessIMPACT OF PARALLEL PATHWAYS OF DRUG ELIMINATION AND MULTIPLE CYTOCHROME P450 INVOLVEMENT ON DRUG-DRUG INTERACTIONS: CYP2D6 PARADIGMKiyomi Ito, David Hallifax, R. Scott Obach and J. Brian HoustonDrug Metabolism and Disposition June 2005, 33 (6) 837-844; DOI: https://doi.org/10.1124/dmd.105.003715
Hsieh, Frank
- You have accessHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITESTeresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald MiwaDrug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
Hu, Ming
- You have accessSPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10Eun Ju Jeong, Yong Liu, Huimin Lin and Ming HuDrug Metabolism and Disposition June 2005, 33 (6) 785-794; DOI: https://doi.org/10.1124/dmd.104.001883
Huebert, Norman
- You have accessDETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDESZhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua ZhongDrug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
I
Inouye, Kuniyo
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
Ito, Kiyomi
- You have accessIMPACT OF PARALLEL PATHWAYS OF DRUG ELIMINATION AND MULTIPLE CYTOCHROME P450 INVOLVEMENT ON DRUG-DRUG INTERACTIONS: CYP2D6 PARADIGMKiyomi Ito, David Hallifax, R. Scott Obach and J. Brian HoustonDrug Metabolism and Disposition June 2005, 33 (6) 837-844; DOI: https://doi.org/10.1124/dmd.105.003715
Iwaki, Masahiro
- You have accessNONLINEAR PHARMACOKINETICS OF PROPAFENONE IN RATS AND HUMANS: APPLICATION OF A SUBSTRATE DEPLETION ASSAY USING HEPATOCYTES FOR ASSESSMENT OF NONLINEARITYHiroshi Komura and Masahiro IwakiDrug Metabolism and Disposition June 2005, 33 (6) 726-732; DOI: https://doi.org/10.1124/dmd.104.002550
Iwasaki, Kazuhide
- You have accessIN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVERMiki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi YokoiDrug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
J
Jeong, Eun Ju
- You have accessSPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10Eun Ju Jeong, Yong Liu, Huimin Lin and Ming HuDrug Metabolism and Disposition June 2005, 33 (6) 785-794; DOI: https://doi.org/10.1124/dmd.104.001883
K
Kamakura, Masaki
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
Katoh, Miki
- You have accessIN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVERMiki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi YokoiDrug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
Kent, Ute M.
- You have accessTHE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATIONNamandjé N. Bumpus, Chitra Sridar, Ute M. Kent and Paul F. HollenbergDrug Metabolism and Disposition June 2005, 33 (6) 795-802; DOI: https://doi.org/10.1124/dmd.105.003749
Kittaka, Atsushi
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
Komura, Hiroshi
- You have accessNONLINEAR PHARMACOKINETICS OF PROPAFENONE IN RATS AND HUMANS: APPLICATION OF A SUBSTRATE DEPLETION ASSAY USING HEPATOCYTES FOR ASSESSMENT OF NONLINEARITYHiroshi Komura and Masahiro IwakiDrug Metabolism and Disposition June 2005, 33 (6) 726-732; DOI: https://doi.org/10.1124/dmd.104.002550
Kunze, Kent L.
- You have accessEVALUATION OF TIME-DEPENDENT INACTIVATION OF CYP3A IN CRYOPRESERVED HUMAN HEPATOCYTESPing Zhao, Kent L. Kunze and Caroline A. LeeDrug Metabolism and Disposition June 2005, 33 (6) 853-861; DOI: https://doi.org/10.1124/dmd.104.002832
Kusudo, Tatsuya
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
L
Labutti, Jason
- You have accessHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITESTeresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald MiwaDrug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
Laufer, Ralph
- You have accessDETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAYAnnalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph LauferDrug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333
Lee, Caroline A.
- You have accessEVALUATION OF TIME-DEPENDENT INACTIVATION OF CYP3A IN CRYOPRESERVED HUMAN HEPATOCYTESPing Zhao, Kent L. Kunze and Caroline A. LeeDrug Metabolism and Disposition June 2005, 33 (6) 853-861; DOI: https://doi.org/10.1124/dmd.104.002832
Lewis, Fred
- You have accessFUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620NR. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
Li, Jian
- You have accessDETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDESZhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua ZhongDrug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
Lin, Huimin
- You have accessSPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10Eun Ju Jeong, Yong Liu, Huimin Lin and Ming HuDrug Metabolism and Disposition June 2005, 33 (6) 785-794; DOI: https://doi.org/10.1124/dmd.104.001883
Liu, Yong
- You have accessSPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10Eun Ju Jeong, Yong Liu, Huimin Lin and Ming HuDrug Metabolism and Disposition June 2005, 33 (6) 785-794; DOI: https://doi.org/10.1124/dmd.104.001883
M
Mao, Qingcheng
- You have accessFUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620NR. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
Masubuchi, Yasuhiro
- You have accessACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMESMasaya Tachibana, Makoto Tanaka, Yasuhiro Masubuchi and Toshiharu HorieDrug Metabolism and Disposition June 2005, 33 (6) 803-811; DOI: https://doi.org/10.1124/dmd.104.003178
Matsui, Tomohito
- You have accessIN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVERMiki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi YokoiDrug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
Mehvar, Reza
- You have accessENZYME-SELECTIVE EFFECTS OF NITRIC OXIDE ON AFFINITY AND MAXIMUM VELOCITY OF VARIOUS RAT CYTOCHROMES P450Ragini Vuppugalla and Reza MehvarDrug Metabolism and Disposition June 2005, 33 (6) 829-836; DOI: https://doi.org/10.1124/dmd.105.003848
Miwa, Gerald
- You have accessHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITESTeresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald MiwaDrug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
N
Nakajima, Miki
- You have accessIN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVERMiki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi YokoiDrug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
Nix, Darrell
- You have accessHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITESTeresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald MiwaDrug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
O
Obach, R. Scott
- You have accessIMPACT OF PARALLEL PATHWAYS OF DRUG ELIMINATION AND MULTIPLE CYTOCHROME P450 INVOLVEMENT ON DRUG-DRUG INTERACTIONS: CYP2D6 PARADIGMKiyomi Ito, David Hallifax, R. Scott Obach and J. Brian HoustonDrug Metabolism and Disposition June 2005, 33 (6) 837-844; DOI: https://doi.org/10.1124/dmd.105.003715
- You have accessIN VITRO-IN VIVO EXTRAPOLATION OF CYP2D6 INACTIVATION BY PAROXETINE: PREDICTION OF NONSTATIONARY PHARMACOKINETICS AND DRUG INTERACTION MAGNITUDEKarthik Venkatakrishnan and R. Scott ObachDrug Metabolism and Disposition June 2005, 33 (6) 845-852; DOI: https://doi.org/10.1124/dmd.105.004077
Ohta, Miho
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
P
Parsons, Ian
- You have accessHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITESTeresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald MiwaDrug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
Pekol, Teresa
- You have accessHUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITESTeresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald MiwaDrug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
Perloff, Elke S.
- You have accessATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITROElke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von MoltkeDrug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931
Persson, Robert
- You have accessCYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATORHelén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric SeidegårdDrug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
Piquette-Miller, Micheline
- You have accessIMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICEGeorgy Hartmann, Vessela Vassileva and Micheline Piquette-MillerDrug Metabolism and Disposition June 2005, 33 (6) 820-828; DOI: https://doi.org/10.1124/dmd.104.002568
Press, Randall J.
- You have accessTHE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATSPeter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. RoseDrug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
R
Rose, James Q.
- You have accessTHE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATSPeter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. RoseDrug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
S
Saito, Nozomi
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
Sakaki, Toshiyuki
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
Schroeder, Patricia E.
- You have accessMETABOLISM OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE AND ONE OF ITS METABOLITES BY ISOLATED RAT MYOCYTES, HEPATOCYTES, AND BLOODPatricia E. Schroeder, Gu-Qi Wang, Frank J. Burczynski and Brian B. HasinoffDrug Metabolism and Disposition June 2005, 33 (6) 719-725; DOI: https://doi.org/10.1124/dmd.104.003186
Seidegård, Janeric
- You have accessCYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATORHelén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric SeidegårdDrug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
Si, Dayong
- You have accessROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANSYingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui ZhouDrug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
Silver, I. S.
- You have accessMETABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTEST. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. ZhaoDrug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
Skipper, Paul L.
- You have accessCHARACTERIZATION OF TESTOSTERONE 11β-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450Man Ho Choi, Paul L. Skipper, John S. Wishnok and Steven R. TannenbaumDrug Metabolism and Disposition June 2005, 33 (6) 714-718; DOI: https://doi.org/10.1124/dmd.104.003327
Skolnik, Paul R.
- You have accessATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITROElke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von MoltkeDrug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931
Soeno, Yoshinori
- You have accessIN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVERMiki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi YokoiDrug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
Souček, Pavel
- You have accessMINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYMEJana Baranová, Eva Anzenbacherová, Pavel Anzenbacher and Pavel SoučekDrug Metabolism and Disposition June 2005, 33 (6) 862-865; DOI: https://doi.org/10.1124/dmd.104.003392
Sparre, Birgitta
- You have accessCYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATORHelén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric SeidegårdDrug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
Sridar, Chitra
- You have accessTHE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATIONNamandjé N. Bumpus, Chitra Sridar, Ute M. Kent and Paul F. HollenbergDrug Metabolism and Disposition June 2005, 33 (6) 795-802; DOI: https://doi.org/10.1124/dmd.105.003749
Stuhler, John
- You have accessTHE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATSPeter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. RoseDrug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
Suhara, Yoshitomo
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
T
Tachibana, Masaya
- You have accessACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMESMasaya Tachibana, Makoto Tanaka, Yasuhiro Masubuchi and Toshiharu HorieDrug Metabolism and Disposition June 2005, 33 (6) 803-811; DOI: https://doi.org/10.1124/dmd.104.003178
Takayama, Hiroaki
- You have accessMETABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo InouyeDrug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
Tanaka, Makoto
- You have accessACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMESMasaya Tachibana, Makoto Tanaka, Yasuhiro Masubuchi and Toshiharu HorieDrug Metabolism and Disposition June 2005, 33 (6) 803-811; DOI: https://doi.org/10.1124/dmd.104.003178
Tannenbaum, Steven R.
- You have accessCHARACTERIZATION OF TESTOSTERONE 11β-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450Man Ho Choi, Paul L. Skipper, John S. Wishnok and Steven R. TannenbaumDrug Metabolism and Disposition June 2005, 33 (6) 714-718; DOI: https://doi.org/10.1124/dmd.104.003327
Tateno, Chise
- You have accessIN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVERMiki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi YokoiDrug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
Tuvesson, Helén
- You have accessCYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATORHelén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric SeidegårdDrug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
Tyler, L. O.
- You have accessMETABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTEST. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. ZhaoDrug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
U
Unadkat, Jashvant D.
- You have accessFUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620NR. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
V
Vassileva, Vessela
- You have accessIMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICEGeorgy Hartmann, Vessela Vassileva and Micheline Piquette-MillerDrug Metabolism and Disposition June 2005, 33 (6) 820-828; DOI: https://doi.org/10.1124/dmd.104.002568
Venkatakrishnan, Karthik
- You have accessIN VITRO-IN VIVO EXTRAPOLATION OF CYP2D6 INACTIVATION BY PAROXETINE: PREDICTION OF NONSTATIONARY PHARMACOKINETICS AND DRUG INTERACTION MAGNITUDEKarthik Venkatakrishnan and R. Scott ObachDrug Metabolism and Disposition June 2005, 33 (6) 845-852; DOI: https://doi.org/10.1124/dmd.105.004077
Vethanayagam, R. Robert
- You have accessFUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620NR. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
von Moltke, Lisa L.
- You have accessATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITROElke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von MoltkeDrug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931
Vuppugalla, Ragini
- You have accessENZYME-SELECTIVE EFFECTS OF NITRIC OXIDE ON AFFINITY AND MAXIMUM VELOCITY OF VARIOUS RAT CYTOCHROMES P450Ragini Vuppugalla and Reza MehvarDrug Metabolism and Disposition June 2005, 33 (6) 829-836; DOI: https://doi.org/10.1124/dmd.105.003848
W
Wang, Gu-Qi
- You have accessMETABOLISM OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE AND ONE OF ITS METABOLITES BY ISOLATED RAT MYOCYTES, HEPATOCYTES, AND BLOODPatricia E. Schroeder, Gu-Qi Wang, Frank J. Burczynski and Brian B. HasinoffDrug Metabolism and Disposition June 2005, 33 (6) 719-725; DOI: https://doi.org/10.1124/dmd.104.003186
Wang, Honggang
- You have accessFUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620NR. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
Wang, Ying
- You have accessROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANSYingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui ZhouDrug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
Wells-Knecht, K.
- You have accessMETABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTEST. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. ZhaoDrug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
Wells-Knecht, M.
- You have accessMETABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTEST. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. ZhaoDrug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
Wishnok, John S.
- You have accessCHARACTERIZATION OF TESTOSTERONE 11β-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450Man Ho Choi, Paul L. Skipper, John S. Wishnok and Steven R. TannenbaumDrug Metabolism and Disposition June 2005, 33 (6) 714-718; DOI: https://doi.org/10.1124/dmd.104.003327
Y
Yan, Zhengyin
- You have accessDETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDESZhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua ZhongDrug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
Yerino, Phyllis
- You have accessTHE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATSPeter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. RoseDrug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
Yokoi, Tsuyoshi
- You have accessIN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVERMiki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi YokoiDrug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
Yoshizato, Katsutoshi
- You have accessIN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVERMiki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi YokoiDrug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
Z
Zhang, Yi
- You have accessFUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620NR. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng MaoDrug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
Zhang, Yifan
- You have accessROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANSYingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui ZhouDrug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
Zhao, Ping
- You have accessEVALUATION OF TIME-DEPENDENT INACTIVATION OF CYP3A IN CRYOPRESERVED HUMAN HEPATOCYTESPing Zhao, Kent L. Kunze and Caroline A. LeeDrug Metabolism and Disposition June 2005, 33 (6) 853-861; DOI: https://doi.org/10.1124/dmd.104.002832
Zhao, Z.
- You have accessMETABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTEST. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. ZhaoDrug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
Zhong, Dafang
- You have accessROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANSYingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui ZhouDrug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
Zhong, Hua
- You have accessDETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDESZhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua ZhongDrug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
Zhou, Hui
- You have accessROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANSYingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui ZhouDrug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616